TFF PHARMACEUTICALS INC. - COMMON STOCK

TFF Pharmaceuticals Announces It Will Wind Down Operations

14 11 2024 16:15:00 提供 Nasdaq GlobeNewswire

TFF Pharmaceuticals’ Technology Generates Superior Inhalational Dry Powder Formulations for Pulmonary Drug Delivery

26 9 2024 07:00:00 提供 Nasdaq GlobeNewswire

TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID

11 9 2024 07:00:00 提供 Nasdaq GlobeNewswire

TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization

10 9 2024 07:00:00 提供 Nasdaq GlobeNewswire

TFF Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

03 9 2024 08:00:00 提供 Nasdaq GlobeNewswire